Funding the Global Response

The ACT-Accelerator, the major global multi-lateral initiative coordinating pandemic response, has requested $16.8 billion in grant funding to support activities from October 2021 to September 2022. At the end of its budget year, ACT-A has raised $5.90 billion, just over one third of the funding needed to implement its strategy. At 70.2% funded, the vaccines pillar fares best ($4.195 billion), while the diagnostics pillar has been allocated $72 million, just 1.5% of the target funding. The lack of funding may be indicative of waning support among wealthier countries for the “no one is safe until everyone is safe” approach.

Source: WHO, updated November 14, 2022
NOTE: These funding targets (tracked at the source listed above) are set for donor countries and differ from those in the ACT-A Strategic Plan, which include expected contributions from development banks and self-funding middle-income countries.

In February 2022, the ACT-Accelerator Facilitation Council’s Finance and Resource Mobilization Working Group, chaired by Norway, set out a “fair share” framework to set contribution benchmarks by country. The calculation of the fair share benchmarks is based on the size of national economies and likely gains from a faster recovery of the global economy and trade.

Source: WHO, updated November 14, 2022

Source: WHO, updated November 14, 2022

At the Second Global COVID-19 Summit, more than $3 billion in new financial commitments were pledged, including about $2.7 from governments and about $700 million from the private sector. Of this new funding, $2.5 billion is dedicated toward COVID-19 response activities and $712 million toward a new pandemic preparedness and global health security financial intermediary fund (FIF) at the World Bank.